<DOC>
	<DOCNO>NCT01884168</DOCNO>
	<brief_summary>To investigate gene expression profile immunological associate analysis relate immunotherapy response patient malignant tumor present malignant cavity effusion DC-CIK immunotherapy .</brief_summary>
	<brief_title>Study Gene Expression Profiling Immunological Mechanism Affects Response Immunotherapy</brief_title>
	<detailed_description>1 . The patient malignant cavity effusion treat dendritic cell ( DC ) plus cytokine induce killer cell ( CIK ) locally . 2 . Malignant cavity effusion cancer patient obtain puncture centrifugalized get supernatant fluid enrich cancer cell therapy . 3 . The enriched cancer cell flash frozen , well supernatant , store -80°C processing . 4 . The T-Cell Receptor/B-Cell Receptor gene expression cavity effusion detect micro-array explore mechanism DC-CIK immunotherapy control malignant cavity effusion . 5 . Statistical analysis perform use unsupervised hierarchical cluster .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>1 . Histologically confirm malignant tumor malignant cavity effusion . 2 . An Eastern Cooperative Oncology Group（ECOG）performance status 02 . 3 . Normal cardiac , hepatic , renal bone marrow function . 4 . Life expectancy &gt; 3 month . 5 . Not receive antitumor treatment . 6 . Not receive chemotherapy pleural abdominal cavity . 1 . Previous history malignancy . 2 . Serious uncontrolled concurrent medical illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>